Seer (SEER) EBIT Margin Growth (1y) (2021 - 2026)
Seer (SEER) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Seer |
95.75 Mn |
95.75 Mn |
982,000.00 |
-12,482.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-12,482.00 |
| Dec 31, 2025 |
-187,501.00 |
| Sep 30, 2025 |
13,385.00 |
| Jun 30, 2025 |
37,524.00 |
| Mar 31, 2025 |
32,865.00 |
| Dec 31, 2024 |
3,907.00 |
| Sep 30, 2024 |
1,768.00 |
| Jun 30, 2024 |
-18,490.00 |
| Mar 31, 2024 |
-14,450.00 |
| Dec 31, 2023 |
196,389.00 |
| Sep 30, 2023 |
1,280.00 |
| Jun 30, 2023 |
-4,996.00 |
| Mar 31, 2023 |
4,102.00 |
| Dec 31, 2022 |
10,643.00 |
| Sep 30, 2022 |
22,149.00 |
| Jun 30, 2022 |
60,253.00 |
| Mar 31, 2022 |
2.59 Mn |
| Dec 31, 2021 |
323,304.00 |
| Sep 30, 2021 |
1.08 Mn |
| Jun 30, 2021 |
771,791.00 |
